摘要
采用随机开放试验设计,研究了22名中国健康男性志愿者单剂量口服5mg他克莫司胶囊的药动学特征。以环孢素D为内标,建立了LC-MS/MS法测定他克莫司在全血中浓度。主要药动学参数为:T1/2(31.4±9.0)h,cmax(41.3±19.6)ng/ml,Tmax(1.7±0.8)h,AUC0-t(330.3±143.5)h·ng·ml-1,AUC0-∝(394.9±186.3)h·ng·ml-1。所得结果与国外文献接近,他克莫司在人体的吸收代谢存在较大的个体变异,变异来源与CYP3A4/5的基因多态性密切相关。
According to an open-label randomized design, pharmacokinetic characteristics of tacrolimus in twenty-two Chinese healthy male volunteers after a single oral dose of 5 mg tacrolimus were discussed. Concentrations of tacrolimus in whole blood were determined by LC-MS/MS and cyclosporin D was used as intemal standard. The pharmacokinetic parameters were as follows: Tv2 (31.4±9.0) h, Cmax (41.3±19.6) ng/ml, Tmax (1.7±0.8) h, AUC0→t (330.3± 143.5) h.ng.ml-1, AUC0→∞ (394.9±186.3)h.ng.ml-1. The results were approximate to those from foreign literature, and there are great inter-individual variations in the absorption and metabolism of tacrolimus in humans due to the close relation with the gene polymorphism of CYP3A4/5.
出处
《中国医药工业杂志》
CAS
CSCD
北大核心
2010年第6期434-437,共4页
Chinese Journal of Pharmaceuticals
基金
国家科技部"国家科技重大新药创制"专项资助(编号2008ZX09312-010)